Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2019
DOI: 10.1016/j.jconrel.2019.01.038
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic vitamin delivery: Chemical and physical methods with future directions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 183 publications
0
5
0
Order By: Relevance
“…independently extracted characteristics of the retrieved RCTs and outcomes of interest from full-text articles. Extracted data involved (1) the number of participants at each stage, (2) participant characteristics, (3) study characteristics (registry, design, ethical approval, country, funding), (4) administered dose of vitamin D3 and methods of delivery, (5) intervention duration, (6) washout period (whenever applicable), (7) participant recruitment sites, (8) assays and kits for determining 25(OH)D levels, (9) baseline and post-intervention results (including 25(OH)D, Ca, and parathyroid hormone (PTH) concentrations), (10) recorded adverse events, (11) drop-outs, and (12) analysis performed (intention-to-treat or per protocol).…”
Section: Data Exctractionmentioning
confidence: 99%
“…independently extracted characteristics of the retrieved RCTs and outcomes of interest from full-text articles. Extracted data involved (1) the number of participants at each stage, (2) participant characteristics, (3) study characteristics (registry, design, ethical approval, country, funding), (4) administered dose of vitamin D3 and methods of delivery, (5) intervention duration, (6) washout period (whenever applicable), (7) participant recruitment sites, (8) assays and kits for determining 25(OH)D levels, (9) baseline and post-intervention results (including 25(OH)D, Ca, and parathyroid hormone (PTH) concentrations), (10) recorded adverse events, (11) drop-outs, and (12) analysis performed (intention-to-treat or per protocol).…”
Section: Data Exctractionmentioning
confidence: 99%
“…However, many studies into the clinical consequences of the lack of VitD are inconclusive (11)(12)(13)(14), and there is a great need for a more complete understanding of the complex biochemical and biophysical properties of this group of compounds (15,16). The development of improved formulations of vitamin D for delivery, including in oral administration, food fortification and for transdermal delivery (17)(18)(19), also remains a topic of interest.…”
Section: Introductionmentioning
confidence: 99%
“…Microencapsulated vitamins are now available as vitamin sources for feed plants, and microencapsulated vitamins have greater stability during storage and processing [3][4][5]. Moreover, microencapsulated vitamins target their release in the small intestine to improve absorption efficiency [6] and regulate vitamin concentrations in the blood through a slow and controlled release in the gastrointestinal tract [6,7]. However, there is a lack of information on the absorption and bioavailability of microencapsulated vitamins in pigs.…”
Section: Introductionmentioning
confidence: 99%